Alexza Pharmaceuticals Overview
- Year Founded
-
2000
- Status
-
Acquired/Merged
- Employees
-
104
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$55M
- Investors
-
1
Alexza Pharmaceuticals General Information
Description
Developer of novel products designed to be used for the acute treatment of central nervous system conditions. The company's novel products are based on the Staccato system, a hand-held inhaler designed to deliver a drug aerosol to the deep lung, providing rapid systemic delivery and therapeutic onset in a non-invasive manner, enabling patients suffering from agitation due to schizophrenia or bipolar I disorder get faster relief.
Contact Information
Website
www.alexza.com(Operating Subsidiary)
Corporate Office
- 2091 Stierlin Court
- Mountain View, CA 94043
- United States
Corporate Office
- 2091 Stierlin Court
- Mountain View, CA 94043
- United States
Alexza Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 16. Merger/Acquisition | 21-Jun-2016 | $55M | Completed | Clinical Trials - Phase 1 | ||
| 15. PIPE | 24-Feb-2016 | Completed | Clinical Trials - Phase 1 | |||
| 14. PIPE | 28-Oct-2014 | Completed | Clinical Trials - Phase 1 | |||
| 13. PIPE | 23-Jul-2012 | Completed | Clinical Trials - Phase 1 | |||
| 12. 2PO | 17-Feb-2012 | Completed | Clinical Trials - Phase 1 | |||
| 11. PIPE | 26-May-2010 | Completed | Clinical Trials - Phase 1 | |||
| 10. Debt - General | 05-May-2010 | Completed | Clinical Trials - Phase 1 | |||
| 9. PIPE | 06-Oct-2009 | Completed | Clinical Trials - Phase 1 | |||
| 8. PIPE | 31-Mar-2008 | $60M | $229M | Completed | Clinical Trials - Phase 1 | |
| 7. 2PO | 05-Jul-2007 | $18.7M | $169M | Completed | Clinical Trials - Phase 1 |
Alexza Pharmaceuticals Comparisons
Industry
Financing
Details
Alexza Pharmaceuticals Competitors (53)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Marinus Pharmaceuticals | Formerly VC-backed | Radnor, PA | ||||
| Acorda Therapeutics | Corporate Backed or Acquired | Ardsley, NY | ||||
| Vivus | Corporate Backed or Acquired | Campbell, CA | ||||
| Promentis Pharmaceuticals | Venture Capital-Backed | Milwaukee, WI | ||||
| Hummingbird Bioscience | Venture Capital-Backed | Singapore, Singapore |
Alexza Pharmaceuticals Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Alexza Pharmaceuticals Patents
Alexza Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20240324679-A1 | Methods and devices for controlling the temperature of a drug foil substrate to generate an aerosol | Pending | 14-Dec-2021 | ||
| US-20210046259-A1 | Electrical condensation aerosol device | Pending | 02-Feb-2018 | ||
| US-20210106775-A1 | Electrical condensation aerosol device | Pending | 02-Feb-2018 | ||
| EP-3746138-A4 | Electrical condensation aerosol device | Pending | 02-Feb-2018 | ||
| EP-3746138-A1 | Electrical condensation aerosol device | Pending | 02-Feb-2018 | A61P11/00 |
Alexza Pharmaceuticals Executive Team (18)
| Name | Title | Board Seat |
|---|---|---|
| Tatjana Naranda Ph.D | President & Chief Operating Officer | |
| Edwin Kamemoto Ph.D | Executive Vice President, Research & Development, Regulatory and Quality | |
| Michael Simms | Senior Vice President, Manufacturing and Operations | |
| Stacy Palermini | Senior Vice President, Sustainability | |
| Chris Kurtz | Vice President, Global Supply Chain |
Alexza Pharmaceuticals Board Members (10)
| Name | Representing | Role | Since |
|---|---|---|---|
| Isaac Stein JD | Self | Lead Director |
Alexza Pharmaceuticals Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Alexza Pharmaceuticals Former Investors (13)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| 5AM Ventures | Venture Capital | Minority | ||
| Abingworth | Venture Capital | Minority | ||
| Alloy Ventures | Venture Capital | Minority | ||
| Azimuth Opportunity | Investment Bank | Minority | ||
| Bio*One Capital | Corporate Venture Capital | Minority |
Alexza Pharmaceuticals Acquisitions (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Symphony Allegro | 26-Aug-2009 | Drug Discovery |
Alexza Pharmaceuticals FAQs
-
When was Alexza Pharmaceuticals founded?
Alexza Pharmaceuticals was founded in 2000.
-
Where is Alexza Pharmaceuticals headquartered?
Alexza Pharmaceuticals is headquartered in Mountain View, CA.
-
What is the size of Alexza Pharmaceuticals?
Alexza Pharmaceuticals has 104 total employees.
-
What industry is Alexza Pharmaceuticals in?
Alexza Pharmaceuticals’s primary industry is Drug Delivery.
-
Is Alexza Pharmaceuticals a private or public company?
Alexza Pharmaceuticals is a Private company.
-
What is the current valuation of Alexza Pharmaceuticals?
The current valuation of Alexza Pharmaceuticals is .
-
What is Alexza Pharmaceuticals’s current revenue?
The current revenue for Alexza Pharmaceuticals is .
-
How much funding has Alexza Pharmaceuticals raised over time?
Alexza Pharmaceuticals has raised $392M.
-
Who are Alexza Pharmaceuticals’s investors?
5AM Ventures, Abingworth, Alloy Ventures, Azimuth Opportunity, and Bio*One Capital are 5 of 13 investors who have invested in Alexza Pharmaceuticals.
-
Who are Alexza Pharmaceuticals’s competitors?
Marinus Pharmaceuticals, Acorda Therapeutics, Vivus, Promentis Pharmaceuticals, and Hummingbird Bioscience are some of the 53 competitors of Alexza Pharmaceuticals.
-
When was Alexza Pharmaceuticals acquired?
Alexza Pharmaceuticals was acquired on 21-Jun-2016.
-
Who acquired Alexza Pharmaceuticals?
Alexza Pharmaceuticals was acquired by Ferrer Internacional.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
